Register Here

Agenda

  • 8:30 am

  • Registration and Continental Breakfast

  • 9:00 am

  • Co-Chair's Opening Remarks

    Ann Daugherty
    Ann Daugherty, PhD

    Senior Manager, Drug Delivery, Genentech

    James Cunningham
    James Cunningham, PhD
    Executive Director, Drug Delivery, Allergan

    SaveSave

    SaveSave

  • 9:15 am

  • Key Trends in Drug Delivery: Expert Perspective

    Randy Mrsny
    Randall Mrsny, PhD

    Professor’s Chair, Department of Pharmacy and Pharmacology, University of Bath

    SaveSave

    SaveSave

  • 9:45 am

  • Physician Perspectives on Current and Future Drug Delivery Needs

    • Drug delivery needs from a physicians point of view
    • What physicians would like to see for their patients
    • Thoughts on making drug administration easier for patients

    Areas of focus include:

    • Oncology
    • Ophthalmology
    • CNS
    • Dermatology

    Moderator:

    Ann Daugherty
    Ann Daugherty, PhD

    Senior Manager, Drug Delivery, Genentech

    Panelists:

    Mark Blumenkranz
    Mark Blumenkranz, MD

    HJ Smead Professor Emeritus in the Department of Ophthalmology, Stanford University


    Krishnan Chakravarthy, MD, PhD

    Assistant Clinical Professor, University of California, San Diego 

    Bruce Kovacs
    Bruce Kovacs, MD

    President & CEO / Physician and Former Director of the Molecular & Cytogenetics Laboratory, Afecta Pharmaceuticals / University of Southern California 


    Julia Ljubimova, MD, PhD

    Director, Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai

    SaveSave

    SaveSave

  • 10:30 am

  • Networking Break & Partnering Meetings

  • 11:10 am

  • Patient Perspectives on Drug Delivery Needs Present and Future

    This panel provides patient perspectives on what they want from drug delivery technologies. We can’t possibly cover every device in this session, but what we can do is to provide case examples that every technology can benefit from and the lessons learned through our patient representatives.

    Co-Moderators:

    Valerie Bowling New
    Valerie Bowling

    Patient Advocate and Executive Director, Drug Delivery West

    Sudeshna Dutta Ray
    Sudeshna Dutta Ray

    Senior Engineer, Advanced Device Technology and Innovation, Amgen

    Panelists:

    Cynthia Goldstein
    Cynthia Goldstein

    Patient & Communications Specialist

    Mikaela Saugstad
    Mikaela Saugstad

    Patient, Co-Founder, Director of Customer Relations & Marketing, Gigil Precision LLC

    Stairs_Lilly_2018
    Lilly Stairs

    Patient and Head of Patient Advocacy, Clara Health

    SaveSave

    SaveSave

  • 11:50 am

  • Pharma Spotlights on Drug Delivery Needs

    In this session, pharma companies discuss their current needs, partnering philosophy and scouting interests, as related to drug delivery.

    James Cunningham
    James Cunningham, PhD

    Executive Director, Drug Delivery, Allergan

    Ann Daugherty
    Ann Daugherty, PhD

    Senior Manager, Drug Delivery, Genentech

    Sudeshna Dutta Ray
    Sudeshna Dutta Ray

    Senior Engineer, Advanced Device Technology and Innovation, Amgen

    John Higgins
    John D Higgins, PhD

    Senior Director and Global Technology Lead, Discovery Pharmaceutical Sciences, Merck Research Labs

    SaveSave

    SaveSave

  • 1:05 pm

  • Lunch & Partnering Meetings

  • 2:20 pm

  • Drug Delivery Global Health Challenge

    Identifying Innovations to Overcome Challenges in Global Health Drug and Vaccine Delivery
    One of the key challenges in global health is ensuring safe and effective delivery of life saving interventions to remote and non-clinical settings. The Bill & Melinda Gates Foundation invests in technologies, which will help achieve this goal. Learn about an RFP they are launching to identify new ideas for delivering lyophilized products and how you can participate.

    David Robinson
    David Robinson, PhD
    Deputy Director, The Bill & Melinda Gates Foundation

    SaveSave

    SaveSave


  • Drug Delivery Presentations

    The afternoon sessions feature companies that will present a wide range of drug delivery technologies, products, or services. These are “quick fire” presentations, with Q&A following each presentation. Throughout the program there are reserved blocks of time for one-on-one partnering meetings to learn more about the technologies and products presented.

    Chaired by:

    Sheldon Moberg
    Sheldon Moberg

    Head of Advanced Device Technologies & Innovation, Amgen

    Presenting Companies:

    SaveSave

    SaveSave

  • 2:30 pm

  • Transforming Oral Delivery Challenges into Valuable Product Solutions

    Learn how Adare experts have successfully formulated patient-centric products with effective taste-masking, targeted, customized and controlled release, as well as optimizing and enhancing bioavailability. Over 40 products across a wide-range of therapeutic areas are commercialized around the world by our partners.

    Cheryl Wood
    Cheryl Wood, MBA

    Director, Business Development, Adare Pharmaceuticals

    SaveSave

    SaveSave

  • 2:45 pm

  • Drug Delivery Experts: Integrating Formulation to Match Delivery Technology and Device

    Specialists in drug product formulation development with premier lab facility located in San Diego, CA. Our team of experts can develop your delivery technology and solve your most challenging problems including solubility, gelation, and injection site reaction issues.

    Chris Rhodes
    Chris Rhodes, PhD

    President & CEO, Drug Delivery Experts

    SaveSave

    SaveSave

  • 3:00 pm

  • Needle-free Injectors, Innovative Drug Delivery to Differentiate your Brand

    Portal Instruments will present their advancements in needle-free drug delivery, designed for home-use self-administration to avoid the hassle of needles.

    Taylor_Barbara copy-bw
    Barbara Taylor

    Senior Director, Marketing, Portal Instruments

    SaveSave

    SaveSave

  • 3:15 pm

  • Efficient Delivery of Therapeutic Cargoes Against Intracellular Targets

    The inefficient delivery of proteins into mammalian cells remains a major barrier to realizing the therapeutic potential of many proteins and nucleic acids. We will describe how Phylogica’s cell-penetrating peptides can efficiently bring proteins and nucleic acids into the cytoplasm of cells.

    Robert Hayes
    Robert Hayes, PhD

    CSO, Phylogica

    SaveSave

    SaveSave

  • 3:30 pm

  • Thermostable Biopharmaceuticals for Mucosal and Transdermal Delivery

    This presentation will focus on VitriLife®, an enabling technology platform that allows mucosal and transdermal delivery of biopharmaceuticals.

    Victor Brohnstein
    Victor Bronshtein, PhD

    President and CSO, Universal Stabilization Technologies

    SaveSave

    SaveSave

  • 3:45 pm

  • Starpharma’s DEP® Platform

    This talk will give a brief overview of Starpharma DEP® platform and provide an update on its clinical pipeline and partnered programs.

    David Owen, PhD

    Vice President, Research, Starpharma

    SaveSave

    SaveSave

  • 4:00 pm

  • Your Way to Deliver More. Introducing Sorrel Medical's Wearable Drug Delivery Platform

    Innovative technology and patient-centric design come together to provide a device platform that is both pre-filled enabled and primary container agnostic. Dr Andrei Yosef, Sorrel Medical’s CEO, is pleased to invite you to an introduction of Sorrel’s Wearable Drug Delivery Platform.

    Andrei Yosef
    Andrei Yosef, PhD

    CEO, Sorrel Medical

    SaveSave

    SaveSave

  • 4:15 pm

  • Approaches for Developing New Therapies for Women & Children

    Targeting this segment of patients is challenging. Afecta will present an overview of our disease and patient focus along with our technologies to better match drugs, indications and tissue targeted drug delivery.

    Bruce Kovacs
    Bruce Kovacs, MD

    President & CEO, Afecta Pharmaceuticals

    SaveSave

    SaveSave

  • 4:30 pm

  • Challenges in Oral Delivery of Biologics Using Drug-Device Combinations

    The talk will focus on challenges and strategies for oral delivery of proteins and peptides. Various formulation strategies and methods for drug-device combinations will be discussed.

    Kiana Aran
    Kiana Aran, PhD

    Assistant Professor, Medical Devices for Diagnostics and Therapeutics, Keck Graduate Institute

    SaveSave

    SaveSave

  • 4:45 pm

  • AdminMed hollow metal microneedle array devices for painless intradermal injections over the large skin area and more effective transdermal drug delivery

    AdminMed, a leading microneedle array company, is producing and selling several hollow metal microneedle array devices in various sizes. AdminPen allows intradermal injections over large skin area for more effective and painless delivery of immunotherapeutics and all other injectable formulations. AdminStamp allows improving absorption of topical formulations. AdminPatch® microneedle patches enable delivering any APIs transdermally.

    Vadim Yuzhakov
    Vadim Yuzhakov, PhD, PMP

    CEO and President, AdminMed

    SaveSave

  • 5:00 pm

  • End of Day One & Networking Reception

Agenda

  • 8:30 am

  • Continental Breakfast

  • 9:00 am

  • Co-Chair’s Opening Remarks

    Ann Daugherty
    Ann Daugherty, PhD

    Senior Manager, Drug Delivery, Genentech

    James Cunningham
    James Cunningham, PhD
    Executive Director, Drug Delivery, Allergan

  • 9:15 am

  • Digital R&D: What Drug Delivery Needs to Be Aware of and its Role on the Future of Design

    This session will provide an overview on the evolving digital landscape in drug development, what drug delivery needs to be aware of and opportunities.

    Jonathan Usuka
    Jonathan Usuka, PhD, MBA

    Senior Analytics Expert, McKinsey & Company

  • 9:45 am

  • How to Innovate in the Drug Delivery Space

    • What does the innovation process look like
    • The barrier to the innovation process and how to overcome them
    • Summary of disease space
    • Good design and engineering practices
    • How to salvage something that goes wrong?  
    • How do you find the unknown unknowns?
    • Does it feel right?


    Uri Baruch

    Head of Drug Delivery, Cambridge Design Partnership

  • 10:15 am

  • Networking Break & Partnering Meetings

  • 10:55 am

  • Precision Medicine KOL Perspective on the Latest Developments and the Future Needs of Drug Delivery

    This session will provide an update on precision/personalized medicine and the impact on drug delivery.

    Presenter TBD

  • 11:20 am

  • Perspectives on Smart Drug Delivery Devices

    gabriel_iobbi
    Gabriel Iobbi, PhD

    Device Portfolio Group Head, Novartis Pharma AG

  • 11:45 am

  • The Unspoken Value of the Design Partner: The Polyglot on the ​Team

    Drug delivery has always been a field complicated by the need to understand and act on the input supplied by doctors, patients, and other non-pharmaceutical stakeholders. At a time when drug delivery companies are expected to design for optimal user interaction, the complexity of the products themselves and mission to provide an innovative experience requires a systematic approach to bridging what technology enables and how people can use it. This challenge can be met through collaboration with an experienced design partner, one who is well versed on cognitive and emotional empathetic human centric approach. Case examples to be provided.

    Kate Stephenson
    Kate Stephenson, PhD

    Academic Partnerships and Business Development, iO life science

  • 12:05 pm

  • Device Design: Current Thinking on Integrating Human Factors and Digital Technologies to Increase Patient Adherence and Satisfaction

    Sherri Biondi
    Sherri Biondi, PhD

    Senior Director, Device Development, Medimmune

  • 12:30 pm

  • Lunch & Partnering Meetings

  • 1:45 pm

  • Investor Perspectives on Drug Delivery Needs and Investments

    • What are investors looking for in the drug delivery sector? 
    • How are early stage technologies evaluated?
    • What makes a start-up attractive for investment?
    • What are the trends and future outlook?

    Moderator:

    Garrett Vygantas
    Garrett Vygantas, MD

    Managing Director,
    OSF Healthcare Ventures

    Panelists:

    Brent Ahrens
    Brent Ahrens

    General Partner, Canaan Partners


    Lori Hu, MBA

    Principal, Vertex Ventures HC

  • 2:30 pm

  • Fireside Chat: Lessons Learned from a Drug Delivery Pioneer and Risk-Taker

    • Basic lessons to learn from
    • What should we be aware of for the future
    • How to make it better

    John Patton
    John Patton, PhD

    Chief Executive Officer and Chairman, Dance Biopharma

    with

    Ann Daugherty
    Ann Daugherty, PhD

    Senior Manager, Drug Delivery, Genentech

  • 3:00 pm

  • Conference Concludes